Harvard Catalyst Profiles
Contact, publication, and social network information about Harvard faculty and fellows.
Home
About
Overview
Open Source Software
Help
History (1)
Ibrutinib selectively targets FLT3-ITD in mutant FLT3-positive AML.
See All Pages
Find People
Find Everything
Login
to
edit your profile
(add a photo, education, awards, etc.), search
student opportunities
, and
create reports
.
Edit My Profile
My Person List (
0
)
Opportunity Search
Return to Top
Ibrutinib selectively targets FLT3-ITD in mutant FLT3-positive AML.
Ibrutinib selectively targets FLT3-ITD in mutant FLT3-positive AML. Leukemia. 2016 Mar; 30(3):754-7.
View in:
PubMed
subject areas
Adenine
Antineoplastic Agents
Apoptosis
Benzamides
Cell Line, Tumor
fms-Like Tyrosine Kinase 3
Gene Expression Regulation, Leukemic
Humans
Leukemia, Myeloid, Acute
Molecular Targeted Therapy
Organ Specificity
Phosphorylation
Piperidines
Protein Kinase Inhibitors
Protein-Tyrosine Kinases
Proto-Oncogene Proteins c-akt
Pyrazoles
Pyrimidines
Signal Transduction
STAT5 Transcription Factor
authors with profiles
Richard M. Stone, M.D.